RPbio Inc. Logo

RPbio Inc.

A global CDMO specializing in soft capsules, pharmaceuticals, and health functional foods.

314140 | KO

Overview

Corporate Details

ISIN(s):
KR7314140005
LEI:
Country:
South Korea
Address:
서울특별시 강남구 삼성로 634, 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RPbio Inc. is a bio-health company specializing in the contract development and manufacturing (CDMO) of soft capsules, pharmaceuticals, and health functional foods. Established in 1983 as a joint venture between Daewoong Pharmaceutical and R.P. Scherer Corporation, the company leverages extensive expertise in advanced softgel technologies. RPbio provides comprehensive OEM/ODM services to domestic and international clients in the pharmaceutical and health supplement industries, positioning itself as a leading global producer of soft capsules.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 703.4 KB
2025-07-22 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-30 00:00
Board/Management Information
대표이사변경
Korean 9.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 623.2 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.7 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 977.6 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.3 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.2 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 69.6 KB
2025-02-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.7 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 619.5 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 775.3 KB
2024-05-14 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 793.3 KB
2024-03-29 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.5 KB

Automate Your Workflow. Get a real-time feed of all RPbio Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RPbio Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RPbio Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Develops advanced therapies for rare lysosomal storage disorders.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America
ANTX
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom
ANAN
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
United States of America
ANAB
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye
ANGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.